Pub. Date : 2011 Aug
PMID : 21868346
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | OBJECTIVE: To evaluate the safety and efficacy of trsatuzumab (Herceptin) combined with FOLFIRI regimen (irinotecan plus 5-FU/LV) in the treatment of HER2-positive advanced gastric cancer. | FOLFIRI regimen | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |
| 2 | CONCLUSION: Trsatuzumab combined with FOLFIRI regimen is effective, safe and well tolerated for treatment of HER2-positive advanced gastric cancer. | FOLFIRI regimen | erb-b2 receptor tyrosine kinase 2 | Homo sapiens |